Programme

Day one:
Tuesday 24 February 2009
08:30   Registration
08:50 Henk Mollee
Director CTM Supply and Operations
Astellas Pharma
Opening remarks from the Chair
           
Successfully managing the clinical supply chain
09:00 Mike Dey
Vice President,
Pharmaceutical Development
Ipsen

Evaluating the performance of the CTS processes using KPIs

  • Establishing accurate KPIs
  • Calculating the success of the supply chain as a whole
  • Ensuring successful supply chain management
09:30

Andrea Zobel
Director, Clinical Logistics, Europe, Clinical Research Services
PAREXEL Inc.

and
Graham Nicholls
Product Manager
Perceptive Informatics

Efficient supply chain management through integrated e-clinical solutions

  • The challenges in effective supply chain management: a depot perspective
  • Using central IP management software across the supply depot network
  • Providing a fully integrated approach to supply chain management and drug accountability by integration with IVR/IWR and drug accountability solutions
10:00  Michael Richter
Global Clinical Trial Coordinator
Roche

Simulating optimal clinical drug supply

  • Assessing the tools and techniques
  • Practical examples: successes and challenges
  • Ensuring an accurate drug supply throughout the clinical trial
10:30   Morning refreshments
11:00 Ed Tourtellotte
President and CEO
Tourtellotte Solutions

and
Paul Skerker
Director, Investigational Supply Operations
Millennium Pharmaceuticals

Case study: global drug pooling

  • The pooling value proposition
  • Regulatory challenges and responses
  • Forecasting, IVRS and labelling
  • Metrics comparison against non-pooled studies
11:30 Angelique Keijzer
Clinical Support Manager
Sanofi Aventis

Exploring CTS: an end user’s perspective

  • Taking the needs of the end user into account when setting up the supply chain
  • Pitfalls at the end of the supply chain
  • Maximising IVRS efficiency and compliance at the user’s level
12:00

Chedia Abdelkafi
Director, Clinical Supplies Solutions
N-Side

Balancing costs and risk to optimise the clinical supply chain: a step beyond simulation

  • Combining simulation and optimisation techniques to make informed decisions
  • A novel approach to supply strategy re-evaluation: applying a Bayesian algorithm to fully leverage IVRS actual data
  • Obtaining a production plan and IVRS inventory management parameters as an output: replacing a “testing” approach by an actual optimisation
  • Operational considerations: how to effectively assess, implement and utilise a forecasting tool
Focusing on investigator initiated trials
12:30 Michael Stephenson
Head of IMSC Europe
Celgene

EU investigator initiated trials: material supply challenges, a perspective

  • Different approaches to material supply for EU IITs
  • Forecasting and planning: is it possible to get accurate information?
  • Distribution: single or multiple shipments?
13:00   Lunch
Meeting the challenges of global clinical trials head-on
14:00 Mark Woolf
Global Depot Manager
Almac

Practicalities of global depot management

  • Ever expanding clinical horizons
  • Considerations prior to study commencement
  • Best supply chain management practices
  • Focusing on controlled substance and cold chain IMP's
14:30 Ying Zhang-Marainen
Director, Clinical Trial Supply Chain Services Business Development - Asia Pacific
Worldcourier

Reviewing CTS in emerging countries

  • Exploring the challenges and trends
  • Difficulties in handling investigational drugs
  • What the sponsors and CROs are looking for
  • Detailing the benefits of in-country solutions
  • Case study: Overcoming regulatory hurdles in China
15:00 Angus Cameron
Director
Pharmarama

Sourcing comparators for clinical trials in India

  • Exploring the Indian pharma market
  • Challenges of procuring comparator drugs
  • Reviewing the necessary documentation needed
  • Managing the logistics and security of supplying lines
Exploring outsourcing aspects of the clinical supply chain
15:30 Anja van Strien
Head Section Investigational Products Supply-Logistics
Schering-Plough

Developing and maintaining a successful sponsor/service provider relationship

  • Vendor selection and management
  • Clear agreements to avoid pitfalls
  • Establishing a personal relationship
16:00   Afternoon refreshments
16:20  Claude Ammann
Director, Quality Assurance/Quality Control
Topotarget

Case study: deciding to outsource or work in-house

  • Examining internal core competencies
  • Objectifying the reasons to outsource
  • Taking a long term strategic view
  • Communicating with the key players
  • Making the decision
Streamlining the distribution network
16:50 Angus MacLeod
Senior Manager, Global Depot Network
Aptuit Ltd

Challenges to controlled drug distribution

  • Exploring facility licenses to store and distribute narcotic clinical trial materials
  • Moving clinical trial materials between countries
  • Analysing different country requirements for different schedules of controlled drugs
17:20   Closing remarks from the Chair and end of day one
17:30   Drinks reception sponsored by Almac
Day two:
Wednesday 25 February 2009
08:30   Registration and coffee
09:00 Dr. Mike Hutton
Client Development Lead
Almac
Opening remarks from the Chair
09:10 Roundtable morning

Delegates will be able to attend three one-hour roundtable discussion groups from a selection of key topics. Each session will be chaired by an industry expert who will facilitate an exchange of opinions, essential experiences and learning related to a current aspect of clinical trial supply.

             
1 Packaging for clinical trials: producing cost effective kits

Robert Smith
Director of Clinical Pharmacy Research Services, Quality Assurance and Qualified Person
Genzyme
2 Understanding the different challenges which need to be met when packaging and labelling for trials in emerging countries

Heike Roeder
Director, Global Head of Clinical Trial Supply Planning
UCB
3 Ensuring investigational products are transported at the correct temperature

Lene Bastholm

Clinical Trial Supply Coordinator
Nycomed
 
             
4 Working towards a flexible supply chain to ease adaptive trial design

Henk Mollee
Director, CTM Supply and Operations
Astellas Pharma and
Michael Herschel
Director of Clinical Research
GlaxoSmithKline
5 Taking clinical, regulatory and sponsor requirements into account to ensure patient compliance when preparing clinical supplies

Hansjoerg Nortmeyer
Supply Chain Trial Manager
Sanofi Aventis
6 Managing expiration to destruction: looking for new tools in the clinical trial supply chain

Dr. Mike Hutton
Client Development Lead
Almac
 
             
12:30   Lunch
Ensuring patient compliance
13:40 Dr David Spackman
Director,
Healthcare Packaging (Europe)
MWV

Patient adherence in the clinic: myth or truth?

  • Focusing on the consequences and costs of sub-optimal adherence
  • Packaging driven strategies to measure and optimise outcomes
  • Best practice techniques to ensure patient adherence
Overcoming packaging and labelling issues for CTS
14:10 Sascha Sonnenberg
Head of Sales and Marketing
Faubel

Supplying multilingual labels for increasingly global clinical trials

  • Constructing a multilingual label
  • Establishing efficient processes to achieve the best results
  • Meeting a wide range of regulations in one design
14:40 Robert Smith
Director of Clinical Pharmacy Research Services, Quality Assurance and Qualified Person
Genzyme

Tackling packaging challenges for clinical trials

  • The need for compliant packaging with maximum flexibility for modification
  • Assessing outsourcing to contract manufacturers
  • Producing cost effective clinical trial kits
15:10   Afternoon refreshments
Reviewing the challenges surrounding drug reconciliation
15:30

Jagath Wanninayake
Vice President,
Clarix Products Group
Phase Forward

Leveraging interactive response systems to manage cost and risk around drug reconciliation

  • Streamlining the drug reconciliation process by eliminating multiple data entry and data discrepancies
  • Eliminating lag of data visibility with access to real time information: speeding up database finalisation
  • Mitigating risks and improving compliance through electronic signatures and edit/logic checks
Looking to the future: CTS with adaptive trials
16:00  Henk Mollee
Director,
Clinical Supply and Operations
Astellas Pharma

Modifying the clinical supply chain to accommodate adaptive trials

  • Understanding how adaptive trials will impact on CTS
  • Adjusting current procedures to facilitate adaptive trials
  • Ensuring flexibility in the supply chain to support adaptive trial design
16:30 Michael Herschel
Director,
Clinical Research
GlaxoSmithKline

Adaptive trial design: optimising the clinical supply process

  • Analysing adaptive trial impact on trial management
  • Reviewing drug production and inventory strategies and drug supply implications
  • Resource needs for adaptive trial designs
  • Cost of adaptive design trial drug supplies (vs standard design trials)
17:00   Closing remarks from the Chair and Champagne prize draw
17:10   End of conference